Yijun Song
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Efficacy and Safety of Traditional Chinese Medicine Qufenghuoxue Formula on Treating Peripheral Neuropathy Induced by Paclitaxel in Advanced Lung Cancer: A Randomized Clinical Trial.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 02, 2025
ELMO2 is a therapeutic vulnerability in mesenchymal-like and drug-resistant non-small cell lung cancer.
Journal: Nature communications
Published: February 25, 2025
OM-85, a Bacterial Lysate, Reduces Pulmonary Nodule Malignant Probability: A Retrospective Study.
Journal: The clinical respiratory journal
Published: February 20, 2025
MET and NF2 alterations confer primary and early resistance to first-line alectinib treatment in ALK-positive non-small-cell lung cancer.
Journal: Molecular oncology
Published: October 08, 2024
Gut microbiota and SCFAs improve the treatment efficacy of chemotherapy and immunotherapy in NSCLC.
Journal: NPJ biofilms and microbiomes
Published: August 28, 2024
Contribution of small airway inflammation to the development of COPD.
Journal: BMC pulmonary medicine
Published: September 11, 2023
Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features.
Journal: Frontiers in oncology
Published: June 09, 2023
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism.
Journal: Thrombosis journal
Published: September 16, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026